Cargando…

Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against Helicobacter pylori and improved ulcer healing

Encapsulation of amoxicillin (AMX) for drug delivery against Helicobacter pylori infection and aspirin-induced ulcers in rat’s stomachs was performed using docosahexaenoic acid (DHA)-loaded chitosan/alginate (CA) nanoparticles (NPs) developed by ionotropic gelation method. The physicochemical analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoshnood, Saeed, Negahdari, Babak, Kaviar, Vahab Hassan, Sadeghifard, Nourkhoda, Abdullah, Mohd Azmuddin, El-Shazly, Mohamed, Haddadi, Mohammad Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948253/ https://www.ncbi.nlm.nih.gov/pubmed/36846798 http://dx.doi.org/10.3389/fmicb.2023.1083330

Ejemplares similares

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2023)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
por: Khoshnood, Saeed, et al.
Publicado: (2021)

Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa
por: Valadbeigi, Hassan, et al.
Publicado: (2023)

Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran
por: Maleki, Abbas, et al.
Publicado: (2022)

The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis
por: Shirani, Maryam, et al.
Publicado: (2023)

Bacteria-derived chimeric toxins as potential anticancer agents
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Persister cells as a possible cause of antibiotic therapy failure in Helicobacter pylori
por: Bahmaninejad, Parvin, et al.
Publicado: (2021)

Microfluidic Encapsulation of Hydrophobic Antifouling Biocides in Calcium Alginate Hydrogels for Controllable Release
por: Liu, Yingzhe, et al.
Publicado: (2020)

Amoxicillin Loaded Chitosan–Alginate Polyelectrolyte Complex Nanoparticles as Mucopenetrating Delivery System for H. Pylori
por: Arora, Saahil, et al.
Publicado: (2011)

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis
por: Kouhsari, Ebrahim, et al.
Publicado: (2022)

Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator‐associated pneumonia
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Genetic and Transcriptomic Variations for Amoxicillin Resistance in Helicobacter pylori under Cryopreservation
por: Han, Xiurui, et al.
Publicado: (2021)

Novel Mutations Conferring Amoxicillin Resistance in Helicobacter pylori in South Korea
por: Park, Soon Young, et al.
Publicado: (2023)

Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion
por: Arora, Saahil, et al.
Publicado: (2012)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
por: Khademi, Farzad, et al.
Publicado: (2013)

Crosstalk between Helicobacter pylori and Gastric Epithelial Cells Is Impaired by Docosahexaenoic Acid
por: Correia, Marta, et al.
Publicado: (2013)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022)

Antiviral effects of azithromycin: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022)

RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS
por: Picoli, Simone Ulrich, et al.
Publicado: (2014)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
por: Kwack, WonGun, et al.
Publicado: (2016)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Docosahexaenoic Acid Inhibits Helicobacter pylori Growth In Vitro and Mice Gastric Mucosa Colonization
por: Correia, Marta, et al.
Publicado: (2012)

Short-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori
por: Hasan, Salman R., et al.
Publicado: (2010)

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
por: Konrad, Paulina, et al.
Publicado: (2018)

Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
por: Zhang, Ya-Wen, et al.
Publicado: (2018)

Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
por: Kasiri, Karam-Ali, et al.
Publicado: (2017)

Effects of Lactobacillus salivarius LN12 in Combination with Amoxicillin and Clarithromycin on Helicobacter pylori Biofilm In Vitro
por: Jin, Fang, et al.
Publicado: (2021)

Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations
por: Grosso, Roberto, et al.
Publicado: (2022)

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori
por: Chen, Xing Xing, et al.
Publicado: (2022)

Dual Therapy Trial Using Esomeprazole and Amoxicillin as Third-line Rescue Therapy for Helicobacter pylori Infection
por: Park, Hyun Kyung, et al.
Publicado: (2011)

Gastric histopathological features after the administration of omeprazole, amoxicillin, and clarithromycin in gastritis Helicobacter pylori rat model
por: Yulizal, OK, et al.
Publicado: (2021)

Enhanced Antibacterial Potential of Amoxicillin against Helicobacter pylori Mediated by Lactobionic Acid Coated Zn-MOFs
por: Haseena,, et al.
Publicado: (2021)

Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam
por: Tran, Trung Thien, et al.
Publicado: (2022)

The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes
por: Attaran, Bahareh, et al.
Publicado: (2021)

A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori
por: Yang, Faming, et al.
Publicado: (2023)

Substitutions in Penicillin-Binding Protein 1 in Amoxicillin-Resistant Helicobacter pylori Strains Isolated from Korean Patients
por: Kim, Beom Jin, et al.
Publicado: (2013)

Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin
por: Sakinc, Türkan, et al.
Publicado: (2012)

Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers
por: Silva, Fernando Marcuz, et al.
Publicado: (2015)

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori
por: Lim, Hyun Chul, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ducnv215i9nqm3lgcm3e757d6t